Aurora Cannabis Inc. ACB
5.11 USD -0.05 (-0.97%)
At closeNov 11, 2026, 4:00 AM EST
4.96 -0.15 -2.87%
Pre-market · Nov 11, 4:00 AM ET
5.09 Day range 5.29
2.56 52-week range 6.36
- YTD
- +21.09%
- 1 year
- +9.42%
News
fool.com The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf Organigram is acquiring Aurora Cannabis. Curaleaf previously made multiple attempts to acquire Aurora in a hostile takeover.
zacks.com Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.09 per share a year…
benzinga.com Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate Aurora Cannabis (TSX:ACB) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.09) by 255.56 percent. This is a 33.33 percent increase over losses of…
businesswire.com Aurora Cannabis Announces Fiscal 2027 Second Quarter Results EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and…
zacks.com Aurora Cannabis Stock: What Organigram's Buyout Means for Investors Aurora Cannabis shares surged after Organigram agreed to a C$561 million buyout, but competing bids, deal conditions and shareholder uncertainty remain.
benzinga.com Aurora Cannabis Stock Surges on Organigram Deal Aurora Cannabis Inc (NASDAQ:ACB) shares are booming Tuesday after the company agreed to be acquired by Organigram Global for 7.80 Canadian dollars ($5.57) per share, a deal that tops a rival hostile…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million. Pasithea Therapeutics (NASDAQ:KTTA) shares increased…
benzinga.com Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share Organigram to acquire Aurora for C$7.80 per Aurora Common Share; Aurora shareholders will have the option to receive such Consideration in cash, Organigram shares or a combination of both, subject to…
benzinga.com Alberta Securities Commission Dismisses Curaleaf Holdings's Application To Halt Aurora Cannabis' February At-The-Market Program Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc.
benzinga.com Curaleaf Demands Engagement From Aurora Amid Fierce Acquisition Dispute Curaleaf condemns Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.
benzinga.com Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s
benzinga.com Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX:ACB) (NASDAQ:ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on